nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiagabine—CYP3A4—Topotecan—ovarian cancer	0.0968	0.354	CbGbCtD
Tiagabine—CYP3A4—Vinorelbine—ovarian cancer	0.0682	0.249	CbGbCtD
Tiagabine—CYP3A4—Paclitaxel—ovarian cancer	0.0479	0.175	CbGbCtD
Tiagabine—CYP3A4—Docetaxel—ovarian cancer	0.0347	0.127	CbGbCtD
Tiagabine—CYP3A4—Doxorubicin—ovarian cancer	0.0258	0.0944	CbGbCtD
Tiagabine—Bronchitis—Epirubicin—ovarian cancer	0.000478	0.000658	CcSEcCtD
Tiagabine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000478	0.000658	CcSEcCtD
Tiagabine—Anaemia—Docetaxel—ovarian cancer	0.000474	0.000653	CcSEcCtD
Tiagabine—Anorexia—Paclitaxel—ovarian cancer	0.000471	0.000648	CcSEcCtD
Tiagabine—Gastritis—Doxorubicin—ovarian cancer	0.000471	0.000648	CcSEcCtD
Tiagabine—Muscular weakness—Doxorubicin—ovarian cancer	0.000469	0.000646	CcSEcCtD
Tiagabine—Vomiting—Vinorelbine—ovarian cancer	0.000467	0.000643	CcSEcCtD
Tiagabine—Dysuria—Epirubicin—ovarian cancer	0.000465	0.00064	CcSEcCtD
Tiagabine—Rash—Vinorelbine—ovarian cancer	0.000463	0.000638	CcSEcCtD
Tiagabine—Dermatitis—Vinorelbine—ovarian cancer	0.000463	0.000637	CcSEcCtD
Tiagabine—Hypotension—Paclitaxel—ovarian cancer	0.000462	0.000636	CcSEcCtD
Tiagabine—Headache—Vinorelbine—ovarian cancer	0.00046	0.000634	CcSEcCtD
Tiagabine—Syncope—Docetaxel—ovarian cancer	0.00046	0.000634	CcSEcCtD
Tiagabine—Asthma—Doxorubicin—ovarian cancer	0.00046	0.000633	CcSEcCtD
Tiagabine—Influenza—Doxorubicin—ovarian cancer	0.00046	0.000633	CcSEcCtD
Tiagabine—Dysphagia—Doxorubicin—ovarian cancer	0.00046	0.000633	CcSEcCtD
Tiagabine—Leukopenia—Docetaxel—ovarian cancer	0.000459	0.000632	CcSEcCtD
Tiagabine—Pollakiuria—Epirubicin—ovarian cancer	0.000459	0.000632	CcSEcCtD
Tiagabine—Palpitations—Docetaxel—ovarian cancer	0.000454	0.000624	CcSEcCtD
Tiagabine—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000454	0.000624	CcSEcCtD
Tiagabine—Weight increased—Epirubicin—ovarian cancer	0.000452	0.000622	CcSEcCtD
Tiagabine—Loss of consciousness—Docetaxel—ovarian cancer	0.000451	0.000621	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00045	0.00062	CcSEcCtD
Tiagabine—Weight decreased—Epirubicin—ovarian cancer	0.00045	0.000619	CcSEcCtD
Tiagabine—Hyperglycaemia—Epirubicin—ovarian cancer	0.000448	0.000617	CcSEcCtD
Tiagabine—Cough—Docetaxel—ovarian cancer	0.000448	0.000617	CcSEcCtD
Tiagabine—Angina pectoris—Doxorubicin—ovarian cancer	0.000448	0.000616	CcSEcCtD
Tiagabine—Insomnia—Paclitaxel—ovarian cancer	0.000447	0.000615	CcSEcCtD
Tiagabine—Pneumonia—Epirubicin—ovarian cancer	0.000446	0.000613	CcSEcCtD
Tiagabine—Paraesthesia—Paclitaxel—ovarian cancer	0.000444	0.000611	CcSEcCtD
Tiagabine—Hypertension—Docetaxel—ovarian cancer	0.000443	0.00061	CcSEcCtD
Tiagabine—Bronchitis—Doxorubicin—ovarian cancer	0.000442	0.000609	CcSEcCtD
Tiagabine—Dyspnoea—Paclitaxel—ovarian cancer	0.000441	0.000606	CcSEcCtD
Tiagabine—Somnolence—Paclitaxel—ovarian cancer	0.000439	0.000605	CcSEcCtD
Tiagabine—Chest pain—Docetaxel—ovarian cancer	0.000437	0.000601	CcSEcCtD
Tiagabine—Myalgia—Docetaxel—ovarian cancer	0.000437	0.000601	CcSEcCtD
Tiagabine—Arthralgia—Docetaxel—ovarian cancer	0.000437	0.000601	CcSEcCtD
Tiagabine—Nausea—Vinorelbine—ovarian cancer	0.000436	0.000601	CcSEcCtD
Tiagabine—Renal failure—Epirubicin—ovarian cancer	0.000435	0.000599	CcSEcCtD
Tiagabine—Dyspepsia—Paclitaxel—ovarian cancer	0.000435	0.000599	CcSEcCtD
Tiagabine—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000434	0.000598	CcSEcCtD
Tiagabine—Stomatitis—Epirubicin—ovarian cancer	0.000432	0.000594	CcSEcCtD
Tiagabine—Conjunctivitis—Epirubicin—ovarian cancer	0.000431	0.000593	CcSEcCtD
Tiagabine—Urinary tract infection—Epirubicin—ovarian cancer	0.000431	0.000593	CcSEcCtD
Tiagabine—Dysuria—Doxorubicin—ovarian cancer	0.00043	0.000592	CcSEcCtD
Tiagabine—Decreased appetite—Paclitaxel—ovarian cancer	0.00043	0.000591	CcSEcCtD
Tiagabine—Dry mouth—Docetaxel—ovarian cancer	0.000427	0.000588	CcSEcCtD
Tiagabine—Fatigue—Paclitaxel—ovarian cancer	0.000426	0.000587	CcSEcCtD
Tiagabine—Sweating—Epirubicin—ovarian cancer	0.000425	0.000585	CcSEcCtD
Tiagabine—Pollakiuria—Doxorubicin—ovarian cancer	0.000425	0.000585	CcSEcCtD
Tiagabine—Constipation—Paclitaxel—ovarian cancer	0.000423	0.000582	CcSEcCtD
Tiagabine—Pain—Paclitaxel—ovarian cancer	0.000423	0.000582	CcSEcCtD
Tiagabine—Haematuria—Epirubicin—ovarian cancer	0.000422	0.000581	CcSEcCtD
Tiagabine—Confusional state—Docetaxel—ovarian cancer	0.000422	0.000581	CcSEcCtD
Tiagabine—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.00042	0.000578	CcSEcCtD
Tiagabine—Oedema—Docetaxel—ovarian cancer	0.000419	0.000577	CcSEcCtD
Tiagabine—Weight increased—Doxorubicin—ovarian cancer	0.000418	0.000576	CcSEcCtD
Tiagabine—Epistaxis—Epirubicin—ovarian cancer	0.000418	0.000575	CcSEcCtD
Tiagabine—Infection—Docetaxel—ovarian cancer	0.000416	0.000573	CcSEcCtD
Tiagabine—Weight decreased—Doxorubicin—ovarian cancer	0.000416	0.000573	CcSEcCtD
Tiagabine—Sinusitis—Epirubicin—ovarian cancer	0.000416	0.000572	CcSEcCtD
Tiagabine—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000415	0.000571	CcSEcCtD
Tiagabine—Pneumonia—Doxorubicin—ovarian cancer	0.000412	0.000568	CcSEcCtD
Tiagabine—Shock—Docetaxel—ovarian cancer	0.000412	0.000567	CcSEcCtD
Tiagabine—Thrombocytopenia—Docetaxel—ovarian cancer	0.00041	0.000565	CcSEcCtD
Tiagabine—Tachycardia—Docetaxel—ovarian cancer	0.000409	0.000563	CcSEcCtD
Tiagabine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000407	0.000561	CcSEcCtD
Tiagabine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000404	0.000556	CcSEcCtD
Tiagabine—Renal failure—Doxorubicin—ovarian cancer	0.000403	0.000555	CcSEcCtD
Tiagabine—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000402	0.000553	CcSEcCtD
Tiagabine—Haemoglobin—Epirubicin—ovarian cancer	0.0004	0.00055	CcSEcCtD
Tiagabine—Stomatitis—Doxorubicin—ovarian cancer	0.0004	0.00055	CcSEcCtD
Tiagabine—Anorexia—Docetaxel—ovarian cancer	0.000399	0.00055	CcSEcCtD
Tiagabine—Rhinitis—Epirubicin—ovarian cancer	0.000399	0.000549	CcSEcCtD
Tiagabine—Conjunctivitis—Doxorubicin—ovarian cancer	0.000398	0.000548	CcSEcCtD
Tiagabine—Urinary tract infection—Doxorubicin—ovarian cancer	0.000398	0.000548	CcSEcCtD
Tiagabine—Haemorrhage—Epirubicin—ovarian cancer	0.000398	0.000547	CcSEcCtD
Tiagabine—Hypoaesthesia—Epirubicin—ovarian cancer	0.000396	0.000545	CcSEcCtD
Tiagabine—Pharyngitis—Epirubicin—ovarian cancer	0.000395	0.000543	CcSEcCtD
Tiagabine—Sweating—Doxorubicin—ovarian cancer	0.000393	0.000541	CcSEcCtD
Tiagabine—Urticaria—Paclitaxel—ovarian cancer	0.000393	0.00054	CcSEcCtD
Tiagabine—Oedema peripheral—Epirubicin—ovarian cancer	0.000392	0.000539	CcSEcCtD
Tiagabine—Hypotension—Docetaxel—ovarian cancer	0.000391	0.000539	CcSEcCtD
Tiagabine—Haematuria—Doxorubicin—ovarian cancer	0.000391	0.000538	CcSEcCtD
Tiagabine—Abdominal pain—Paclitaxel—ovarian cancer	0.000391	0.000538	CcSEcCtD
Tiagabine—Body temperature increased—Paclitaxel—ovarian cancer	0.000391	0.000538	CcSEcCtD
Tiagabine—Epistaxis—Doxorubicin—ovarian cancer	0.000387	0.000532	CcSEcCtD
Tiagabine—Sinusitis—Doxorubicin—ovarian cancer	0.000385	0.000529	CcSEcCtD
Tiagabine—Visual impairment—Epirubicin—ovarian cancer	0.000383	0.000528	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000382	0.000525	CcSEcCtD
Tiagabine—Insomnia—Docetaxel—ovarian cancer	0.000379	0.000522	CcSEcCtD
Tiagabine—Paraesthesia—Docetaxel—ovarian cancer	0.000376	0.000518	CcSEcCtD
Tiagabine—Dyspnoea—Docetaxel—ovarian cancer	0.000373	0.000514	CcSEcCtD
Tiagabine—Somnolence—Docetaxel—ovarian cancer	0.000372	0.000513	CcSEcCtD
Tiagabine—Tinnitus—Epirubicin—ovarian cancer	0.000371	0.00051	CcSEcCtD
Tiagabine—Haemoglobin—Doxorubicin—ovarian cancer	0.00037	0.000509	CcSEcCtD
Tiagabine—Rhinitis—Doxorubicin—ovarian cancer	0.000369	0.000508	CcSEcCtD
Tiagabine—Dyspepsia—Docetaxel—ovarian cancer	0.000369	0.000508	CcSEcCtD
Tiagabine—Haemorrhage—Doxorubicin—ovarian cancer	0.000368	0.000507	CcSEcCtD
Tiagabine—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000366	0.000504	CcSEcCtD
Tiagabine—Pharyngitis—Doxorubicin—ovarian cancer	0.000365	0.000503	CcSEcCtD
Tiagabine—Decreased appetite—Docetaxel—ovarian cancer	0.000364	0.000501	CcSEcCtD
Tiagabine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000364	0.000501	CcSEcCtD
Tiagabine—Oedema peripheral—Doxorubicin—ovarian cancer	0.000363	0.000499	CcSEcCtD
Tiagabine—Fatigue—Docetaxel—ovarian cancer	0.000361	0.000497	CcSEcCtD
Tiagabine—Pain—Docetaxel—ovarian cancer	0.000358	0.000493	CcSEcCtD
Tiagabine—Constipation—Docetaxel—ovarian cancer	0.000358	0.000493	CcSEcCtD
Tiagabine—Chills—Epirubicin—ovarian cancer	0.000357	0.000491	CcSEcCtD
Tiagabine—Visual impairment—Doxorubicin—ovarian cancer	0.000355	0.000488	CcSEcCtD
Tiagabine—Asthenia—Paclitaxel—ovarian cancer	0.000355	0.000488	CcSEcCtD
Tiagabine—Alopecia—Epirubicin—ovarian cancer	0.000351	0.000484	CcSEcCtD
Tiagabine—Pruritus—Paclitaxel—ovarian cancer	0.00035	0.000481	CcSEcCtD
Tiagabine—Feeling abnormal—Docetaxel—ovarian cancer	0.000345	0.000475	CcSEcCtD
Tiagabine—Tinnitus—Doxorubicin—ovarian cancer	0.000343	0.000472	CcSEcCtD
Tiagabine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000343	0.000472	CcSEcCtD
Tiagabine—Flatulence—Epirubicin—ovarian cancer	0.000341	0.00047	CcSEcCtD
Tiagabine—Tension—Epirubicin—ovarian cancer	0.00034	0.000468	CcSEcCtD
Tiagabine—Dysgeusia—Epirubicin—ovarian cancer	0.000339	0.000467	CcSEcCtD
Tiagabine—Diarrhoea—Paclitaxel—ovarian cancer	0.000338	0.000465	CcSEcCtD
Tiagabine—Nervousness—Epirubicin—ovarian cancer	0.000336	0.000463	CcSEcCtD
Tiagabine—Back pain—Epirubicin—ovarian cancer	0.000335	0.000461	CcSEcCtD
Tiagabine—Muscle spasms—Epirubicin—ovarian cancer	0.000333	0.000458	CcSEcCtD
Tiagabine—Abdominal pain—Docetaxel—ovarian cancer	0.000331	0.000456	CcSEcCtD
Tiagabine—Body temperature increased—Docetaxel—ovarian cancer	0.000331	0.000456	CcSEcCtD
Tiagabine—Chills—Doxorubicin—ovarian cancer	0.00033	0.000454	CcSEcCtD
Tiagabine—Dizziness—Paclitaxel—ovarian cancer	0.000327	0.00045	CcSEcCtD
Tiagabine—Alopecia—Doxorubicin—ovarian cancer	0.000325	0.000448	CcSEcCtD
Tiagabine—Ill-defined disorder—Epirubicin—ovarian cancer	0.000321	0.000442	CcSEcCtD
Tiagabine—Anaemia—Epirubicin—ovarian cancer	0.00032	0.00044	CcSEcCtD
Tiagabine—Agitation—Epirubicin—ovarian cancer	0.000318	0.000438	CcSEcCtD
Tiagabine—Flatulence—Doxorubicin—ovarian cancer	0.000316	0.000434	CcSEcCtD
Tiagabine—Tension—Doxorubicin—ovarian cancer	0.000314	0.000433	CcSEcCtD
Tiagabine—Vomiting—Paclitaxel—ovarian cancer	0.000314	0.000433	CcSEcCtD
Tiagabine—Dysgeusia—Doxorubicin—ovarian cancer	0.000314	0.000432	CcSEcCtD
Tiagabine—Malaise—Epirubicin—ovarian cancer	0.000312	0.00043	CcSEcCtD
Tiagabine—Rash—Paclitaxel—ovarian cancer	0.000312	0.000429	CcSEcCtD
Tiagabine—Dermatitis—Paclitaxel—ovarian cancer	0.000311	0.000429	CcSEcCtD
Tiagabine—Nervousness—Doxorubicin—ovarian cancer	0.000311	0.000428	CcSEcCtD
Tiagabine—Vertigo—Epirubicin—ovarian cancer	0.000311	0.000428	CcSEcCtD
Tiagabine—Syncope—Epirubicin—ovarian cancer	0.00031	0.000427	CcSEcCtD
Tiagabine—Leukopenia—Epirubicin—ovarian cancer	0.00031	0.000427	CcSEcCtD
Tiagabine—Back pain—Doxorubicin—ovarian cancer	0.00031	0.000427	CcSEcCtD
Tiagabine—Headache—Paclitaxel—ovarian cancer	0.00031	0.000426	CcSEcCtD
Tiagabine—Hypersensitivity—Docetaxel—ovarian cancer	0.000309	0.000425	CcSEcCtD
Tiagabine—Muscle spasms—Doxorubicin—ovarian cancer	0.000308	0.000424	CcSEcCtD
Tiagabine—Palpitations—Epirubicin—ovarian cancer	0.000306	0.000421	CcSEcCtD
Tiagabine—Loss of consciousness—Epirubicin—ovarian cancer	0.000304	0.000419	CcSEcCtD
Tiagabine—Cough—Epirubicin—ovarian cancer	0.000302	0.000416	CcSEcCtD
Tiagabine—Asthenia—Docetaxel—ovarian cancer	0.000301	0.000414	CcSEcCtD
Tiagabine—Hypertension—Epirubicin—ovarian cancer	0.000299	0.000411	CcSEcCtD
Tiagabine—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000297	0.000409	CcSEcCtD
Tiagabine—Pruritus—Docetaxel—ovarian cancer	0.000296	0.000408	CcSEcCtD
Tiagabine—Anaemia—Doxorubicin—ovarian cancer	0.000296	0.000408	CcSEcCtD
Tiagabine—Chest pain—Epirubicin—ovarian cancer	0.000295	0.000406	CcSEcCtD
Tiagabine—Arthralgia—Epirubicin—ovarian cancer	0.000295	0.000406	CcSEcCtD
Tiagabine—Myalgia—Epirubicin—ovarian cancer	0.000295	0.000406	CcSEcCtD
Tiagabine—Agitation—Doxorubicin—ovarian cancer	0.000294	0.000405	CcSEcCtD
Tiagabine—Anxiety—Epirubicin—ovarian cancer	0.000294	0.000404	CcSEcCtD
Tiagabine—Nausea—Paclitaxel—ovarian cancer	0.000294	0.000404	CcSEcCtD
Tiagabine—Discomfort—Epirubicin—ovarian cancer	0.000291	0.000401	CcSEcCtD
Tiagabine—Malaise—Doxorubicin—ovarian cancer	0.000289	0.000398	CcSEcCtD
Tiagabine—Dry mouth—Epirubicin—ovarian cancer	0.000288	0.000397	CcSEcCtD
Tiagabine—Vertigo—Doxorubicin—ovarian cancer	0.000288	0.000396	CcSEcCtD
Tiagabine—Syncope—Doxorubicin—ovarian cancer	0.000287	0.000395	CcSEcCtD
Tiagabine—Leukopenia—Doxorubicin—ovarian cancer	0.000287	0.000395	CcSEcCtD
Tiagabine—Diarrhoea—Docetaxel—ovarian cancer	0.000287	0.000395	CcSEcCtD
Tiagabine—Confusional state—Epirubicin—ovarian cancer	0.000285	0.000392	CcSEcCtD
Tiagabine—Palpitations—Doxorubicin—ovarian cancer	0.000283	0.00039	CcSEcCtD
Tiagabine—Oedema—Epirubicin—ovarian cancer	0.000283	0.000389	CcSEcCtD
Tiagabine—Loss of consciousness—Doxorubicin—ovarian cancer	0.000282	0.000388	CcSEcCtD
Tiagabine—Infection—Epirubicin—ovarian cancer	0.000281	0.000386	CcSEcCtD
Tiagabine—Cough—Doxorubicin—ovarian cancer	0.00028	0.000385	CcSEcCtD
Tiagabine—Shock—Epirubicin—ovarian cancer	0.000278	0.000383	CcSEcCtD
Tiagabine—Dizziness—Docetaxel—ovarian cancer	0.000277	0.000381	CcSEcCtD
Tiagabine—Thrombocytopenia—Epirubicin—ovarian cancer	0.000277	0.000381	CcSEcCtD
Tiagabine—Hypertension—Doxorubicin—ovarian cancer	0.000277	0.000381	CcSEcCtD
Tiagabine—Tachycardia—Epirubicin—ovarian cancer	0.000276	0.00038	CcSEcCtD
Tiagabine—Hyperhidrosis—Epirubicin—ovarian cancer	0.000273	0.000376	CcSEcCtD
Tiagabine—Arthralgia—Doxorubicin—ovarian cancer	0.000273	0.000375	CcSEcCtD
Tiagabine—Myalgia—Doxorubicin—ovarian cancer	0.000273	0.000375	CcSEcCtD
Tiagabine—Chest pain—Doxorubicin—ovarian cancer	0.000273	0.000375	CcSEcCtD
Tiagabine—Anxiety—Doxorubicin—ovarian cancer	0.000272	0.000374	CcSEcCtD
Tiagabine—Discomfort—Doxorubicin—ovarian cancer	0.000269	0.000371	CcSEcCtD
Tiagabine—Anorexia—Epirubicin—ovarian cancer	0.000269	0.000371	CcSEcCtD
Tiagabine—Dry mouth—Doxorubicin—ovarian cancer	0.000267	0.000367	CcSEcCtD
Tiagabine—Vomiting—Docetaxel—ovarian cancer	0.000266	0.000367	CcSEcCtD
Tiagabine—Rash—Docetaxel—ovarian cancer	0.000264	0.000364	CcSEcCtD
Tiagabine—Hypotension—Epirubicin—ovarian cancer	0.000264	0.000363	CcSEcCtD
Tiagabine—Dermatitis—Docetaxel—ovarian cancer	0.000264	0.000363	CcSEcCtD
Tiagabine—Confusional state—Doxorubicin—ovarian cancer	0.000264	0.000363	CcSEcCtD
Tiagabine—Headache—Docetaxel—ovarian cancer	0.000262	0.000361	CcSEcCtD
Tiagabine—Oedema—Doxorubicin—ovarian cancer	0.000261	0.00036	CcSEcCtD
Tiagabine—Infection—Doxorubicin—ovarian cancer	0.00026	0.000358	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000257	0.000354	CcSEcCtD
Tiagabine—Shock—Doxorubicin—ovarian cancer	0.000257	0.000354	CcSEcCtD
Tiagabine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000256	0.000352	CcSEcCtD
Tiagabine—Insomnia—Epirubicin—ovarian cancer	0.000256	0.000352	CcSEcCtD
Tiagabine—Tachycardia—Doxorubicin—ovarian cancer	0.000255	0.000351	CcSEcCtD
Tiagabine—Paraesthesia—Epirubicin—ovarian cancer	0.000254	0.000349	CcSEcCtD
Tiagabine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000253	0.000348	CcSEcCtD
Tiagabine—Dyspnoea—Epirubicin—ovarian cancer	0.000252	0.000347	CcSEcCtD
Tiagabine—Somnolence—Epirubicin—ovarian cancer	0.000251	0.000346	CcSEcCtD
Tiagabine—Anorexia—Doxorubicin—ovarian cancer	0.000249	0.000343	CcSEcCtD
Tiagabine—Nausea—Docetaxel—ovarian cancer	0.000249	0.000342	CcSEcCtD
Tiagabine—Dyspepsia—Epirubicin—ovarian cancer	0.000249	0.000342	CcSEcCtD
Tiagabine—Decreased appetite—Epirubicin—ovarian cancer	0.000246	0.000338	CcSEcCtD
Tiagabine—Hypotension—Doxorubicin—ovarian cancer	0.000244	0.000336	CcSEcCtD
Tiagabine—Fatigue—Epirubicin—ovarian cancer	0.000244	0.000335	CcSEcCtD
Tiagabine—Pain—Epirubicin—ovarian cancer	0.000242	0.000333	CcSEcCtD
Tiagabine—Constipation—Epirubicin—ovarian cancer	0.000242	0.000333	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000238	0.000328	CcSEcCtD
Tiagabine—Insomnia—Doxorubicin—ovarian cancer	0.000236	0.000325	CcSEcCtD
Tiagabine—Paraesthesia—Doxorubicin—ovarian cancer	0.000235	0.000323	CcSEcCtD
Tiagabine—Dyspnoea—Doxorubicin—ovarian cancer	0.000233	0.000321	CcSEcCtD
Tiagabine—Feeling abnormal—Epirubicin—ovarian cancer	0.000233	0.00032	CcSEcCtD
Tiagabine—Somnolence—Doxorubicin—ovarian cancer	0.000232	0.00032	CcSEcCtD
Tiagabine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000231	0.000318	CcSEcCtD
Tiagabine—Dyspepsia—Doxorubicin—ovarian cancer	0.00023	0.000317	CcSEcCtD
Tiagabine—Decreased appetite—Doxorubicin—ovarian cancer	0.000227	0.000313	CcSEcCtD
Tiagabine—Fatigue—Doxorubicin—ovarian cancer	0.000225	0.00031	CcSEcCtD
Tiagabine—Urticaria—Epirubicin—ovarian cancer	0.000224	0.000309	CcSEcCtD
Tiagabine—Pain—Doxorubicin—ovarian cancer	0.000224	0.000308	CcSEcCtD
Tiagabine—Constipation—Doxorubicin—ovarian cancer	0.000224	0.000308	CcSEcCtD
Tiagabine—Abdominal pain—Epirubicin—ovarian cancer	0.000223	0.000307	CcSEcCtD
Tiagabine—Body temperature increased—Epirubicin—ovarian cancer	0.000223	0.000307	CcSEcCtD
Tiagabine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000215	0.000297	CcSEcCtD
Tiagabine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000214	0.000294	CcSEcCtD
Tiagabine—Hypersensitivity—Epirubicin—ovarian cancer	0.000208	0.000287	CcSEcCtD
Tiagabine—Urticaria—Doxorubicin—ovarian cancer	0.000208	0.000286	CcSEcCtD
Tiagabine—Body temperature increased—Doxorubicin—ovarian cancer	0.000207	0.000284	CcSEcCtD
Tiagabine—Abdominal pain—Doxorubicin—ovarian cancer	0.000207	0.000284	CcSEcCtD
Tiagabine—Asthenia—Epirubicin—ovarian cancer	0.000203	0.000279	CcSEcCtD
Tiagabine—Pruritus—Epirubicin—ovarian cancer	0.0002	0.000275	CcSEcCtD
Tiagabine—Diarrhoea—Epirubicin—ovarian cancer	0.000193	0.000266	CcSEcCtD
Tiagabine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000193	0.000265	CcSEcCtD
Tiagabine—Asthenia—Doxorubicin—ovarian cancer	0.000188	0.000258	CcSEcCtD
Tiagabine—Dizziness—Epirubicin—ovarian cancer	0.000187	0.000257	CcSEcCtD
Tiagabine—Pruritus—Doxorubicin—ovarian cancer	0.000185	0.000255	CcSEcCtD
Tiagabine—Vomiting—Epirubicin—ovarian cancer	0.00018	0.000247	CcSEcCtD
Tiagabine—Diarrhoea—Doxorubicin—ovarian cancer	0.000179	0.000246	CcSEcCtD
Tiagabine—Rash—Epirubicin—ovarian cancer	0.000178	0.000245	CcSEcCtD
Tiagabine—Dermatitis—Epirubicin—ovarian cancer	0.000178	0.000245	CcSEcCtD
Tiagabine—Headache—Epirubicin—ovarian cancer	0.000177	0.000244	CcSEcCtD
Tiagabine—Dizziness—Doxorubicin—ovarian cancer	0.000173	0.000238	CcSEcCtD
Tiagabine—Nausea—Epirubicin—ovarian cancer	0.000168	0.000231	CcSEcCtD
Tiagabine—Vomiting—Doxorubicin—ovarian cancer	0.000166	0.000229	CcSEcCtD
Tiagabine—Rash—Doxorubicin—ovarian cancer	0.000165	0.000227	CcSEcCtD
Tiagabine—Dermatitis—Doxorubicin—ovarian cancer	0.000165	0.000227	CcSEcCtD
Tiagabine—Headache—Doxorubicin—ovarian cancer	0.000164	0.000225	CcSEcCtD
Tiagabine—Nausea—Doxorubicin—ovarian cancer	0.000155	0.000214	CcSEcCtD
